Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hanover Bancorp, Inc. /ny (HNVR) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hanover Bancorp, Inc. /ny. Table 2 shows the detailed insider transactions. This company's CIK number is 1828588.
Total stock buying since 2022: $1,487,580.
Total stock sales since 2022: $1,180,076.
Total stock option exercises since 2022: $1,450,344.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 39,510 | $968,722 | 42,000 | $262,500 |
2024 | 10,990 | $190,007 | 7,500 | $191,400 | 98,392 | $983,920 |
2023 | 265 | $4,770 | 1,124 | $19,954 | 33,400 | $168,354 |
2022 | 61,565 | $1,292,803 | 0 | $0 | 3,557 | $35,570 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-05 | 0 | $0 | 23,860 | $553,433 | 0 | $0 |
2025-02 | 0 | $0 | 13,378 | $354,675 | 42,000 | $262,500 |
2025-01 | 0 | $0 | 2,272 | $60,614 | 0 | $0 |
2024-12 | 0 | $0 | 7,500 | $191,400 | 0 | $0 |
2024-11 | 215 | $5,048 | 0 | $0 | 0 | $0 |
2024-09 | 0 | $0 | 0 | $0 | 3,217 | $32,170 |
2024-08 | 100 | $1,714 | 0 | $0 | 79,979 | $799,790 |
2024-06 | 2,000 | $32,735 | 0 | $0 | 0 | $0 |
2024-05 | 575 | $9,554 | 0 | $0 | 0 | $0 |
2024-04 | 4,150 | $69,815 | 0 | $0 | 7,057 | $70,570 |
2024-03 | 0 | $0 | 0 | $0 | 8,139 | $81,390 |
2024-01 | 3,950 | $71,141 | 0 | $0 | 0 | $0 |
2023-12 | 0 | $0 | 1,124 | $19,954 | 33,400 | $168,354 |
2023-11 | 265 | $4,770 | 0 | $0 | 0 | $0 |
2022-12 | 0 | $0 | 0 | $0 | 3,557 | $35,570 |
2022-08 | 65 | $1,303 | 0 | $0 | 0 | $0 |
2022-05 | 61,500 | $1,291,500 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-09 | Golden Robert (Director) | Sale | 10,000 | 23.07 | 230,720 |
2025-05-08 | Golden Robert (Director) | Sale | 6,829 | 23.24 | 158,705 |
2025-05-06 | Golden Robert (Director) | Sale | 1,708 | 23.04 | 39,359 |
2025-05-05 | Golden Robert (Director) | Sale | 323 | 23.40 | 7,559 |
2025-05-02 | Golden Robert (Director) | Sale | 5,000 | 23.42 | 117,090 |
2025-02-07 | Golden Robert (Director) | Sale | 2,601 | 26.06 | 67,784 |
2025-02-06 | Wilcox Mcclelland W (President) | Option Ex | 42,000 | 6.25 | 262,500 |
2025-02-06 | Golden Robert (Director) | Sale | 2,596 | 26.62 | 69,118 |
2025-02-05 | Golden Robert (Director) | Sale | 2,761 | 26.61 | 73,475 |
2025-02-04 | Golden Robert (Director) | Sale | 2,920 | 26.66 | 77,838 |
2025-02-03 | Golden Robert (Director) | Sale | 2,500 | 26.58 | 66,460 |
2025-01-31 | Golden Robert (Director) | Sale | 2,272 | 26.68 | 60,614 |
2024-12-10 | Katz Michael David M.d. (Director) | Sale | 5,000 | 25.53 | 127,650 |
2024-12-10 | Golden Robert (Director) | Sale | 2,500 | 25.50 | 63,750 |
2024-11-22 | Sisti Elena (Director) | Buy | 215 | 23.48 | 5,048 |
2024-09-10 | Abraham Varkey (Director) | Option Ex | 3,217 | 10.00 | 32,170 |
2024-08-28 | Puorro Michael P (Chairman & CEO) | Option Ex | 71,840 | 10.00 | 718,400 |
2024-08-26 | Haspel Ahron H (Director) | Option Ex | 8,139 | 10.00 | 81,390 |
2024-08-20 | Okun Philip A (Director) | Buy | 100 | 17.14 | 1,714 |
2024-06-14 | Okun Philip A (Director) | Buy | 500 | 16.49 | 8,245 |
2024-06-13 | Okun Philip A (Director) | Buy | 500 | 16.47 | 8,235 |
2024-06-12 | Okun Philip A (Director) | Buy | 500 | 16.25 | 8,125 |
2024-06-11 | Okun Philip A (Director) | Buy | 500 | 16.26 | 8,130 |
2024-05-03 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 175 | 16.61 | 2,906 |
2024-05-02 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 200 | 16.57 | 3,314 |
2024-05-01 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 200 | 16.67 | 3,334 |
2024-04-30 | Wilcox Mcclelland W (President) | Buy | 250 | 16.60 | 4,150 |
2024-04-30 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 200 | 16.60 | 3,320 |
2024-04-30 | Puorro Michael P (Chairman & CEO) | Buy | 500 | 16.60 | 8,300 |
2024-04-24 | Vivona John P (FSVP & Chief Risk Officer) | Buy | 200 | 16.79 | 3,357 |
2024-04-24 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 200 | 16.78 | 3,356 |
2024-04-24 | Puorro Michael P (Chairman & CEO) | Buy | 200 | 16.78 | 3,356 |
2024-04-23 | Puorro Michael P (Chairman & CEO) | Buy | 200 | 16.90 | 3,379 |
2024-04-22 | Wilcox Mcclelland W (President) | Buy | 200 | 16.91 | 3,382 |
2024-04-22 | Sisti Elena (Director) | Buy | 2,000 | 16.95 | 33,900 |
2024-04-22 | Puorro Michael P (Chairman & CEO) | Buy | 200 | 16.58 | 3,315 |
2024-04-09 | Katz Michael David M.d. (Director) | Option Ex | 7,057 | 10.00 | 70,570 |
2024-03-05 | Okun Philip A (Director) | Option Ex | 8,139 | 10.00 | 81,390 |
2024-01-31 | Golden Robert (Director) | Buy | 500 | 18.00 | 9,000 |
2024-01-29 | Katz Michael David M.d. (Director) | Buy | 700 | 18.02 | 12,614 |
2024-01-29 | Sisti Elena (Director) | Buy | 2,750 | 18.01 | 49,527 |
2023-12-26 | Wilcox Mcclelland W (President) | Option Ex | 29,900 | 4.46 | 133,354 |
2023-12-08 | Okun Philip A (Director) | Sale | 1,124 | 17.75 | 19,954 |
2023-12-06 | Sorrenti John R (Director) | Option Ex | 3,500 | 10.00 | 35,000 |
2023-11-08 | Sisti Elena (Director) | Buy | 265 | 18.00 | 4,770 |
2022-12-01 | Sorrenti John R (Director) | Option Ex | 3,557 | 10.00 | 35,570 |
2022-08-12 | Katz Michael David M.d. (Director) | Buy | 40 | 20.11 | 804 |
2022-08-11 | Katz Michael David M.d. (Director) | Buy | 25 | 19.99 | 499 |
2022-05-11 | Katz Michael David M.d. (Director) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Corbett Kevin (EVP & Chief Credit Officer) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Wilcox Mcclelland W (SEVP, C.Lending & Revenue Off.) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Sorrenti John R (Director) | Buy | 2,500 | 21.00 | 52,500 |
2022-05-11 | Sisti Elena (Director) | Buy | 8,000 | 21.00 | 168,000 |
2022-05-11 | Negrin Metin (Director) | Buy | 8,000 | 21.00 | 168,000 |
2022-05-11 | Okun Philip A (Director) | Buy | 3,000 | 21.00 | 63,000 |
2022-05-11 | Rouse Alice T (EVP & Chief Risk Officer) | Buy | 2,000 | 21.00 | 42,000 |
2022-05-11 | Burke Lance P (EVP & Chief Financial Officer) | Buy | 2,000 | 21.00 | 42,000 |
2022-05-11 | Diiorio Lisa A (FSVP & Chief Accounting Off.) | Buy | 1,000 | 21.00 | 21,000 |
2022-05-11 | Abraham Varkey (Director) | Buy | 2,500 | 21.00 | 52,500 |
2022-05-11 | Golden Robert (Director) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Haspel Ahron H (Director) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Puorro Michael P (Chairman & CEO) | Buy | 5,000 | 21.00 | 105,000 |
2022-05-11 | Finneran Brian K (President) | Buy | 2,500 | 21.00 | 52,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of HNVR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hanover Bancorp, Inc. /ny (symbol HNVR, CIK number 1828588) see the Securities and Exchange Commission (SEC) website.